Details

Last Funding Type

Seed

Last Funding Money Raised

£499.84K

Industries

Biotechnology,Machine Learning

Founded date

Jan 1, 2018

Number Of Employee

11 - 50

Operating Status

Active

Concr is an emerging software platform to combat cancer. It combines cutting edge machine learning techniques with a deep scientific understanding of tumour progression to accurately predict cancer evolution in response to treatment.

This will enable clinicians to adapt treatments proactively, rather than reactively, to prevent treatment resistance and improve treatment efficacy through precision medicine.
Concr aims to:

• Reduce treatment resistance
• Cut the cost of cancer treatment
• Enable proactive treatment adaptation
• Save lives